img

Global Alogliptin Benzoate Tablet Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Alogliptin Benzoate Tablet Market Research Report 2024

Alogliptin Benzoate Tablet, this product is suitable for the treatment of type 2 diabetes mellitus. 1) Monotherapy This product is used as an adjunct therapy for diet control and exercise to improve blood glucose control in patients with type 2 diabetes mellitus. 2) Combined with metformin hydrochloride When metformin hydrochloride alone cannot effectively control blood glucose, this product can be used in combination with metformin hydrochloride to improve blood glucose control in patients with type 2 diabetes on the basis of diet and exercise. 3) Important Limitations of use This product is not intended for use in patients with type 1 diabetes or diabetic ketoacidosis as its effectiveness has not been determined.
According to Mr Accuracy reports’s new survey, global Alogliptin Benzoate Tablet market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Alogliptin Benzoate Tablet market research.
Key manufacturers engaged in the Alogliptin Benzoate Tablet industry include Takeda Pharmaceutical, Perrigo, Navana Pharmaceuticals, China National Medicines Guorui Pharmaceutical, Reyoung Pharmaceutical, Yichang HEC ChangJiang Pharmaceutical, Chongqing Kerui Nanhai Pharmaceutical, Yabao Pharmaceutical and Zhejiang Huabett Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Alogliptin Benzoate Tablet were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Alogliptin Benzoate Tablet market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Alogliptin Benzoate Tablet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Takeda Pharmaceutical
Perrigo
Navana Pharmaceuticals
China National Medicines Guorui Pharmaceutical
Reyoung Pharmaceutical
Yichang HEC ChangJiang Pharmaceutical
Chongqing Kerui Nanhai Pharmaceutical
Yabao Pharmaceutical
Zhejiang Huabett Pharmaceutical
Sunshine Lake Pharma
Jiangsu Deyuan Pharmaceutical
Qianjin Xiangjiang Pharmageuical
CSPC Ouyi Pharmaceutical
Shenzhen Haibin Pharmaceutical
Segment by Type
6.25mg/Tablet
12.5mg/Tablet
25mg/Tablet

Segment by Application


Hospital
Clinic
Pharmacy

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Alogliptin Benzoate Tablet report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Alogliptin Benzoate Tablet Market Overview
1.1 Product Overview and Scope of Alogliptin Benzoate Tablet
1.2 Alogliptin Benzoate Tablet Segment by Type
1.2.1 Global Alogliptin Benzoate Tablet Market Value Comparison by Type (2024-2034)
1.2.2 6.25mg/Tablet
1.2.3 12.5mg/Tablet
1.2.4 25mg/Tablet
1.3 Alogliptin Benzoate Tablet Segment by Application
1.3.1 Global Alogliptin Benzoate Tablet Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Alogliptin Benzoate Tablet Market Size Estimates and Forecasts
1.4.1 Global Alogliptin Benzoate Tablet Revenue 2024-2034
1.4.2 Global Alogliptin Benzoate Tablet Sales 2024-2034
1.4.3 Global Alogliptin Benzoate Tablet Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Alogliptin Benzoate Tablet Market Competition by Manufacturers
2.1 Global Alogliptin Benzoate Tablet Sales Market Share by Manufacturers (2024-2024)
2.2 Global Alogliptin Benzoate Tablet Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Alogliptin Benzoate Tablet Average Price by Manufacturers (2024-2024)
2.4 Global Alogliptin Benzoate Tablet Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Alogliptin Benzoate Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alogliptin Benzoate Tablet, Product Type & Application
2.7 Alogliptin Benzoate Tablet Market Competitive Situation and Trends
2.7.1 Alogliptin Benzoate Tablet Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Alogliptin Benzoate Tablet Players Market Share by Revenue
2.7.3 Global Alogliptin Benzoate Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alogliptin Benzoate Tablet Retrospective Market Scenario by Region
3.1 Global Alogliptin Benzoate Tablet Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Alogliptin Benzoate Tablet Global Alogliptin Benzoate Tablet Sales by Region: 2024-2034
3.2.1 Global Alogliptin Benzoate Tablet Sales by Region: 2024-2024
3.2.2 Global Alogliptin Benzoate Tablet Sales by Region: 2024-2034
3.3 Global Alogliptin Benzoate Tablet Global Alogliptin Benzoate Tablet Revenue by Region: 2024-2034
3.3.1 Global Alogliptin Benzoate Tablet Revenue by Region: 2024-2024
3.3.2 Global Alogliptin Benzoate Tablet Revenue by Region: 2024-2034
3.4 North America Alogliptin Benzoate Tablet Market Facts & Figures by Country
3.4.1 North America Alogliptin Benzoate Tablet Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Alogliptin Benzoate Tablet Sales by Country (2024-2034)
3.4.3 North America Alogliptin Benzoate Tablet Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Alogliptin Benzoate Tablet Market Facts & Figures by Country
3.5.1 Europe Alogliptin Benzoate Tablet Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Alogliptin Benzoate Tablet Sales by Country (2024-2034)
3.5.3 Europe Alogliptin Benzoate Tablet Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alogliptin Benzoate Tablet Market Facts & Figures by Country
3.6.1 Asia Pacific Alogliptin Benzoate Tablet Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Alogliptin Benzoate Tablet Sales by Country (2024-2034)
3.6.3 Asia Pacific Alogliptin Benzoate Tablet Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Alogliptin Benzoate Tablet Market Facts & Figures by Country
3.7.1 Latin America Alogliptin Benzoate Tablet Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Alogliptin Benzoate Tablet Sales by Country (2024-2034)
3.7.3 Latin America Alogliptin Benzoate Tablet Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alogliptin Benzoate Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Alogliptin Benzoate Tablet Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Alogliptin Benzoate Tablet Sales by Country (2024-2034)
3.8.3 Middle East and Africa Alogliptin Benzoate Tablet Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alogliptin Benzoate Tablet Sales by Type (2024-2034)
4.1.1 Global Alogliptin Benzoate Tablet Sales by Type (2024-2024)
4.1.2 Global Alogliptin Benzoate Tablet Sales by Type (2024-2034)
4.1.3 Global Alogliptin Benzoate Tablet Sales Market Share by Type (2024-2034)
4.2 Global Alogliptin Benzoate Tablet Revenue by Type (2024-2034)
4.2.1 Global Alogliptin Benzoate Tablet Revenue by Type (2024-2024)
4.2.2 Global Alogliptin Benzoate Tablet Revenue by Type (2024-2034)
4.2.3 Global Alogliptin Benzoate Tablet Revenue Market Share by Type (2024-2034)
4.3 Global Alogliptin Benzoate Tablet Price by Type (2024-2034)
5 Segment by Application
5.1 Global Alogliptin Benzoate Tablet Sales by Application (2024-2034)
5.1.1 Global Alogliptin Benzoate Tablet Sales by Application (2024-2024)
5.1.2 Global Alogliptin Benzoate Tablet Sales by Application (2024-2034)
5.1.3 Global Alogliptin Benzoate Tablet Sales Market Share by Application (2024-2034)
5.2 Global Alogliptin Benzoate Tablet Revenue by Application (2024-2034)
5.2.1 Global Alogliptin Benzoate Tablet Revenue by Application (2024-2024)
5.2.2 Global Alogliptin Benzoate Tablet Revenue by Application (2024-2034)
5.2.3 Global Alogliptin Benzoate Tablet Revenue Market Share by Application (2024-2034)
5.3 Global Alogliptin Benzoate Tablet Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Takeda Pharmaceutical
6.1.1 Takeda Pharmaceutical Corporation Information
6.1.2 Takeda Pharmaceutical Description and Business Overview
6.1.3 Takeda Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Takeda Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.1.5 Takeda Pharmaceutical Recent Developments/Updates
6.2 Perrigo
6.2.1 Perrigo Corporation Information
6.2.2 Perrigo Description and Business Overview
6.2.3 Perrigo Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Perrigo Alogliptin Benzoate Tablet Product Portfolio
6.2.5 Perrigo Recent Developments/Updates
6.3 Navana Pharmaceuticals
6.3.1 Navana Pharmaceuticals Corporation Information
6.3.2 Navana Pharmaceuticals Description and Business Overview
6.3.3 Navana Pharmaceuticals Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Navana Pharmaceuticals Alogliptin Benzoate Tablet Product Portfolio
6.3.5 Navana Pharmaceuticals Recent Developments/Updates
6.4 China National Medicines Guorui Pharmaceutical
6.4.1 China National Medicines Guorui Pharmaceutical Corporation Information
6.4.2 China National Medicines Guorui Pharmaceutical Description and Business Overview
6.4.3 China National Medicines Guorui Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2024-2024)
6.4.4 China National Medicines Guorui Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.4.5 China National Medicines Guorui Pharmaceutical Recent Developments/Updates
6.5 Reyoung Pharmaceutical
6.5.1 Reyoung Pharmaceutical Corporation Information
6.5.2 Reyoung Pharmaceutical Description and Business Overview
6.5.3 Reyoung Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Reyoung Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.5.5 Reyoung Pharmaceutical Recent Developments/Updates
6.6 Yichang HEC ChangJiang Pharmaceutical
6.6.1 Yichang HEC ChangJiang Pharmaceutical Corporation Information
6.6.2 Yichang HEC ChangJiang Pharmaceutical Description and Business Overview
6.6.3 Yichang HEC ChangJiang Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Yichang HEC ChangJiang Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.6.5 Yichang HEC ChangJiang Pharmaceutical Recent Developments/Updates
6.7 Chongqing Kerui Nanhai Pharmaceutical
6.6.1 Chongqing Kerui Nanhai Pharmaceutical Corporation Information
6.6.2 Chongqing Kerui Nanhai Pharmaceutical Description and Business Overview
6.6.3 Chongqing Kerui Nanhai Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Chongqing Kerui Nanhai Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.7.5 Chongqing Kerui Nanhai Pharmaceutical Recent Developments/Updates
6.8 Yabao Pharmaceutical
6.8.1 Yabao Pharmaceutical Corporation Information
6.8.2 Yabao Pharmaceutical Description and Business Overview
6.8.3 Yabao Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Yabao Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.8.5 Yabao Pharmaceutical Recent Developments/Updates
6.9 Zhejiang Huabett Pharmaceutical
6.9.1 Zhejiang Huabett Pharmaceutical Corporation Information
6.9.2 Zhejiang Huabett Pharmaceutical Description and Business Overview
6.9.3 Zhejiang Huabett Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Zhejiang Huabett Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.9.5 Zhejiang Huabett Pharmaceutical Recent Developments/Updates
6.10 Sunshine Lake Pharma
6.10.1 Sunshine Lake Pharma Corporation Information
6.10.2 Sunshine Lake Pharma Description and Business Overview
6.10.3 Sunshine Lake Pharma Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Sunshine Lake Pharma Alogliptin Benzoate Tablet Product Portfolio
6.10.5 Sunshine Lake Pharma Recent Developments/Updates
6.11 Jiangsu Deyuan Pharmaceutical
6.11.1 Jiangsu Deyuan Pharmaceutical Corporation Information
6.11.2 Jiangsu Deyuan Pharmaceutical Alogliptin Benzoate Tablet Description and Business Overview
6.11.3 Jiangsu Deyuan Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Jiangsu Deyuan Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.11.5 Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
6.12 Qianjin Xiangjiang Pharmageuical
6.12.1 Qianjin Xiangjiang Pharmageuical Corporation Information
6.12.2 Qianjin Xiangjiang Pharmageuical Alogliptin Benzoate Tablet Description and Business Overview
6.12.3 Qianjin Xiangjiang Pharmageuical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Qianjin Xiangjiang Pharmageuical Alogliptin Benzoate Tablet Product Portfolio
6.12.5 Qianjin Xiangjiang Pharmageuical Recent Developments/Updates
6.13 CSPC Ouyi Pharmaceutical
6.13.1 CSPC Ouyi Pharmaceutical Corporation Information
6.13.2 CSPC Ouyi Pharmaceutical Alogliptin Benzoate Tablet Description and Business Overview
6.13.3 CSPC Ouyi Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2024-2024)
6.13.4 CSPC Ouyi Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.13.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.14 Shenzhen Haibin Pharmaceutical
6.14.1 Shenzhen Haibin Pharmaceutical Corporation Information
6.14.2 Shenzhen Haibin Pharmaceutical Alogliptin Benzoate Tablet Description and Business Overview
6.14.3 Shenzhen Haibin Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Shenzhen Haibin Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.14.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alogliptin Benzoate Tablet Industry Chain Analysis
7.2 Alogliptin Benzoate Tablet Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alogliptin Benzoate Tablet Production Mode & Process
7.4 Alogliptin Benzoate Tablet Sales and Marketing
7.4.1 Alogliptin Benzoate Tablet Sales Channels
7.4.2 Alogliptin Benzoate Tablet Distributors
7.5 Alogliptin Benzoate Tablet Customers
8 Alogliptin Benzoate Tablet Market Dynamics
8.1 Alogliptin Benzoate Tablet Industry Trends
8.2 Alogliptin Benzoate Tablet Market Drivers
8.3 Alogliptin Benzoate Tablet Market Challenges
8.4 Alogliptin Benzoate Tablet Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Alogliptin Benzoate Tablet Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Alogliptin Benzoate Tablet Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Alogliptin Benzoate Tablet Market Competitive Situation by Manufacturers in 2022
Table 4. Global Alogliptin Benzoate Tablet Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Alogliptin Benzoate Tablet Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Alogliptin Benzoate Tablet Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Alogliptin Benzoate Tablet Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Alogliptin Benzoate Tablet Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Alogliptin Benzoate Tablet, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Alogliptin Benzoate Tablet, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Alogliptin Benzoate Tablet, Product Type & Application
Table 12. Global Key Manufacturers of Alogliptin Benzoate Tablet, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alogliptin Benzoate Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alogliptin Benzoate Tablet as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Alogliptin Benzoate Tablet Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Alogliptin Benzoate Tablet Sales by Region (2024-2024) & (K Units)
Table 18. Global Alogliptin Benzoate Tablet Sales Market Share by Region (2024-2024)
Table 19. Global Alogliptin Benzoate Tablet Sales by Region (2024-2034) & (K Units)
Table 20. Global Alogliptin Benzoate Tablet Sales Market Share by Region (2024-2034)
Table 21. Global Alogliptin Benzoate Tablet Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Alogliptin Benzoate Tablet Revenue Market Share by Region (2024-2024)
Table 23. Global Alogliptin Benzoate Tablet Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Alogliptin Benzoate Tablet Revenue Market Share by Region (2024-2034)
Table 25. North America Alogliptin Benzoate Tablet Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Alogliptin Benzoate Tablet Sales by Country (2024-2024) & (K Units)
Table 27. North America Alogliptin Benzoate Tablet Sales by Country (2024-2034) & (K Units)
Table 28. North America Alogliptin Benzoate Tablet Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Alogliptin Benzoate Tablet Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Alogliptin Benzoate Tablet Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Alogliptin Benzoate Tablet Sales by Country (2024-2024) & (K Units)
Table 32. Europe Alogliptin Benzoate Tablet Sales by Country (2024-2034) & (K Units)
Table 33. Europe Alogliptin Benzoate Tablet Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Alogliptin Benzoate Tablet Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Alogliptin Benzoate Tablet Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Alogliptin Benzoate Tablet Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Alogliptin Benzoate Tablet Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Alogliptin Benzoate Tablet Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Alogliptin Benzoate Tablet Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Alogliptin Benzoate Tablet Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Alogliptin Benzoate Tablet Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Alogliptin Benzoate Tablet Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Alogliptin Benzoate Tablet Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Alogliptin Benzoate Tablet Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Alogliptin Benzoate Tablet Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Alogliptin Benzoate Tablet Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Alogliptin Benzoate Tablet Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Alogliptin Benzoate Tablet Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Alogliptin Benzoate Tablet Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Alogliptin Benzoate Tablet Sales (K Units) by Type (2024-2024)
Table 51. Global Alogliptin Benzoate Tablet Sales (K Units) by Type (2024-2034)
Table 52. Global Alogliptin Benzoate Tablet Sales Market Share by Type (2024-2024)
Table 53. Global Alogliptin Benzoate Tablet Sales Market Share by Type (2024-2034)
Table 54. Global Alogliptin Benzoate Tablet Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Alogliptin Benzoate Tablet Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Alogliptin Benzoate Tablet Revenue Market Share by Type (2024-2024)
Table 57. Global Alogliptin Benzoate Tablet Revenue Market Share by Type (2024-2034)
Table 58. Global Alogliptin Benzoate Tablet Price (US$/Unit) by Type (2024-2024)
Table 59. Global Alogliptin Benzoate Tablet Price (US$/Unit) by Type (2024-2034)
Table 60. Global Alogliptin Benzoate Tablet Sales (K Units) by Application (2024-2024)
Table 61. Global Alogliptin Benzoate Tablet Sales (K Units) by Application (2024-2034)
Table 62. Global Alogliptin Benzoate Tablet Sales Market Share by Application (2024-2024)
Table 63. Global Alogliptin Benzoate Tablet Sales Market Share by Application (2024-2034)
Table 64. Global Alogliptin Benzoate Tablet Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Alogliptin Benzoate Tablet Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Alogliptin Benzoate Tablet Revenue Market Share by Application (2024-2024)
Table 67. Global Alogliptin Benzoate Tablet Revenue Market Share by Application (2024-2034)
Table 68. Global Alogliptin Benzoate Tablet Price (US$/Unit) by Application (2024-2024)
Table 69. Global Alogliptin Benzoate Tablet Price (US$/Unit) by Application (2024-2034)
Table 70. Takeda Pharmaceutical Corporation Information
Table 71. Takeda Pharmaceutical Description and Business Overview
Table 72. Takeda Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Takeda Pharmaceutical Alogliptin Benzoate Tablet Product
Table 74. Takeda Pharmaceutical Recent Developments/Updates
Table 75. Perrigo Corporation Information
Table 76. Perrigo Description and Business Overview
Table 77. Perrigo Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Perrigo Alogliptin Benzoate Tablet Product
Table 79. Perrigo Recent Developments/Updates
Table 80. Navana Pharmaceuticals Corporation Information
Table 81. Navana Pharmaceuticals Description and Business Overview
Table 82. Navana Pharmaceuticals Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Navana Pharmaceuticals Alogliptin Benzoate Tablet Product
Table 84. Navana Pharmaceuticals Recent Developments/Updates
Table 85. China National Medicines Guorui Pharmaceutical Corporation Information
Table 86. China National Medicines Guorui Pharmaceutical Description and Business Overview
Table 87. China National Medicines Guorui Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. China National Medicines Guorui Pharmaceutical Alogliptin Benzoate Tablet Product
Table 89. China National Medicines Guorui Pharmaceutical Recent Developments/Updates
Table 90. Reyoung Pharmaceutical Corporation Information
Table 91. Reyoung Pharmaceutical Description and Business Overview
Table 92. Reyoung Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Reyoung Pharmaceutical Alogliptin Benzoate Tablet Product
Table 94. Reyoung Pharmaceutical Recent Developments/Updates
Table 95. Yichang HEC ChangJiang Pharmaceutical Corporation Information
Table 96. Yichang HEC ChangJiang Pharmaceutical Description and Business Overview
Table 97. Yichang HEC ChangJiang Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Yichang HEC ChangJiang Pharmaceutical Alogliptin Benzoate Tablet Product
Table 99. Yichang HEC ChangJiang Pharmaceutical Recent Developments/Updates
Table 100. Chongqing Kerui Nanhai Pharmaceutical Corporation Information
Table 101. Chongqing Kerui Nanhai Pharmaceutical Description and Business Overview
Table 102. Chongqing Kerui Nanhai Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Chongqing Kerui Nanhai Pharmaceutical Alogliptin Benzoate Tablet Product
Table 104. Chongqing Kerui Nanhai Pharmaceutical Recent Developments/Updates
Table 105. Yabao Pharmaceutical Corporation Information
Table 106. Yabao Pharmaceutical Description and Business Overview
Table 107. Yabao Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Yabao Pharmaceutical Alogliptin Benzoate Tablet Product
Table 109. Yabao Pharmaceutical Recent Developments/Updates
Table 110. Zhejiang Huabett Pharmaceutical Corporation Information
Table 111. Zhejiang Huabett Pharmaceutical Description and Business Overview
Table 112. Zhejiang Huabett Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Zhejiang Huabett Pharmaceutical Alogliptin Benzoate Tablet Product
Table 114. Zhejiang Huabett Pharmaceutical Recent Developments/Updates
Table 115. Sunshine Lake Pharma Corporation Information
Table 116. Sunshine Lake Pharma Description and Business Overview
Table 117. Sunshine Lake Pharma Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Sunshine Lake Pharma Alogliptin Benzoate Tablet Product
Table 119. Sunshine Lake Pharma Recent Developments/Updates
Table 120. Jiangsu Deyuan Pharmaceutical Corporation Information
Table 121. Jiangsu Deyuan Pharmaceutical Description and Business Overview
Table 122. Jiangsu Deyuan Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Jiangsu Deyuan Pharmaceutical Alogliptin Benzoate Tablet Product
Table 124. Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
Table 125. Qianjin Xiangjiang Pharmageuical Corporation Information
Table 126. Qianjin Xiangjiang Pharmageuical Description and Business Overview
Table 127. Qianjin Xiangjiang Pharmageuical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Qianjin Xiangjiang Pharmageuical Alogliptin Benzoate Tablet Product
Table 129. Qianjin Xiangjiang Pharmageuical Recent Developments/Updates
Table 130. CSPC Ouyi Pharmaceutical Corporation Information
Table 131. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 132. CSPC Ouyi Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. CSPC Ouyi Pharmaceutical Alogliptin Benzoate Tablet Product
Table 134. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 135. Shenzhen Haibin Pharmaceutical Corporation Information
Table 136. Shenzhen Haibin Pharmaceutical Description and Business Overview
Table 137. Shenzhen Haibin Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Shenzhen Haibin Pharmaceutical Alogliptin Benzoate Tablet Product
Table 139. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Alogliptin Benzoate Tablet Distributors List
Table 143. Alogliptin Benzoate Tablet Customers List
Table 144. Alogliptin Benzoate Tablet Market Trends
Table 145. Alogliptin Benzoate Tablet Market Drivers
Table 146. Alogliptin Benzoate Tablet Market Challenges
Table 147. Alogliptin Benzoate Tablet Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Alogliptin Benzoate Tablet
Figure 2. Global Alogliptin Benzoate Tablet Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Alogliptin Benzoate Tablet Market Share by Type in 2022 & 2034
Figure 4. 6.25mg/Tablet Product Picture
Figure 5. 12.5mg/Tablet Product Picture
Figure 6. 25mg/Tablet Product Picture
Figure 7. Global Alogliptin Benzoate Tablet Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Alogliptin Benzoate Tablet Market Share by Application in 2022 & 2034
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Pharmacy
Figure 12. Global Alogliptin Benzoate Tablet Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global Alogliptin Benzoate Tablet Market Size (2024-2034) & (US$ Million)
Figure 14. Global Alogliptin Benzoate Tablet Sales (2024-2034) & (K Units)
Figure 15. Global Alogliptin Benzoate Tablet Average Price (US$/Unit) & (2024-2034)
Figure 16. Alogliptin Benzoate Tablet Report Years Considered
Figure 17. Alogliptin Benzoate Tablet Sales Share by Manufacturers in 2022
Figure 18. Global Alogliptin Benzoate Tablet Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Alogliptin Benzoate Tablet Players: Market Share by Revenue in 2022
Figure 20. Alogliptin Benzoate Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 21. Global Alogliptin Benzoate Tablet Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 22. North America Alogliptin Benzoate Tablet Sales Market Share by Country (2024-2034)
Figure 23. North America Alogliptin Benzoate Tablet Revenue Market Share by Country (2024-2034)
Figure 24. United States Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Canada Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 26. Europe Alogliptin Benzoate Tablet Sales Market Share by Country (2024-2034)
Figure 27. Europe Alogliptin Benzoate Tablet Revenue Market Share by Country (2024-2034)
Figure 28. Germany Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. France Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. U.K. Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Italy Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Russia Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Asia Pacific Alogliptin Benzoate Tablet Sales Market Share by Region (2024-2034)
Figure 34. Asia Pacific Alogliptin Benzoate Tablet Revenue Market Share by Region (2024-2034)
Figure 35. China Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Japan Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. South Korea Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. India Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Australia Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. China Taiwan Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Southeast Asia Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Latin America Alogliptin Benzoate Tablet Sales Market Share by Country (2024-2034)
Figure 43. Latin America Alogliptin Benzoate Tablet Revenue Market Share by Country (2024-2034)
Figure 44. Mexico Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Brazil Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Argentina Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Middle East & Africa Alogliptin Benzoate Tablet Sales Market Share by Country (2024-2034)
Figure 48. Middle East & Africa Alogliptin Benzoate Tablet Revenue Market Share by Country (2024-2034)
Figure 49. Turkey Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Saudi Arabia Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. UAE Alogliptin Benzoate Tablet Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Alogliptin Benzoate Tablet by Type (2024-2034)
Figure 53. Global Revenue Market Share of Alogliptin Benzoate Tablet by Type (2024-2034)
Figure 54. Global Alogliptin Benzoate Tablet Price (US$/Unit) by Type (2024-2034)
Figure 55. Global Sales Market Share of Alogliptin Benzoate Tablet by Application (2024-2034)
Figure 56. Global Revenue Market Share of Alogliptin Benzoate Tablet by Application (2024-2034)
Figure 57. Global Alogliptin Benzoate Tablet Price (US$/Unit) by Application (2024-2034)
Figure 58. Alogliptin Benzoate Tablet Value Chain
Figure 59. Alogliptin Benzoate Tablet Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed